In hepatocellular carcinoma, CD133+ cells are resistant to doxorubicin and fluorouracil, and this is attributed to expression of bcl-2, Akt and PKB, components of an anti-apoptotic survival pathway 83. Here, AKT1 is linked to hepatocellular carcinoma.